Ambev's investment thesis centers on its fortress balance sheet and robust cash generation, evidenced by a debt-to-equity ratio of 0.03 and cumulative operating cash flow of $58.5B over the last ten quarters, which supports substantial shareholder returns. The...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth remains stable near zero (0.3% YoY in 2026Q2) due to FX distortions, but gross margin expanded to 51.9% from 50.0% a year earlier, driven by premiumization and cost discipline, while operating margin improved to 23.6% from 21.9%.
Ambev S.A. has trailing and forward P/E ratios of 13.45 and 13.26 respectively, indicating a potentially undervalued stock.
The bullish thesis highlights Ambev's strong position in emerging markets, which offers significant growth potential.
Ambev is focusing on premiumization, which could drive higher margins and revenue growth in its product offerings.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 30, 2026 | $0.04+0.0% vs $0.04 | $4.0B-1.9% vs $4.1B |
Q2 2026 May 5, 2026 | $0.05+0.0% vs $0.05 | $4.6B+4.2% vs $4.4B |
Q1 2026 Feb 12, 2026 | $0.05+0.0% vs $0.05 | $5.2B+13.1% vs $4.6B |
Q4 2025 Oct 30, 2025 | $0.04+0.0% vs $0.04 | $3.9B-2.9% vs $4.0B |
Archford Capital Strategies LLC trimmed its position in shares of Ambev S.A. (NYSE: ABEV) by 33.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 688,742 shares of the company's stock after selling 352,698 shares during the period. Archford Capital
Ambev remains a Buy, supported by strong Q2 results, margin expansion, and reaffirmed 2026 guidance amid a challenging macro environment. ABEV delivered 6.1% net revenue growth, 8.9% Normalized EBITDA growth, and 24% Normalized EPS growth, with robust market share gains in Brazil. Valuation remains compelling, with intrinsic value estimated above current levels, implying a significant discount and margin of safety while Brazil's general election is near.
Bank of America Corp DE lessened its stake in Ambev S.A. (NYSE: ABEV) by 51.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,305,441 shares of the company's stock after selling 17,313,628 shares during the period. Bank of America
Ambev S.A. (ABEV) Q2 2026 Earnings Call Transcript
Benchmark ABEV against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ambev S.A. (ABEV)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.93 | $45.7B | 15.33 | -1.35% | 17.57% | 16.46% | 8.59% | |
| $77.06 | $148.81B | 22.27 | -0.75% | 13.04% | 16.84% | — | |
| $36.62 | $6.87B | -3.38 | -4.18% | -20.81% | -21.98% | — | |
| $167.69 | $1.75B | 16.96 | 3.69% | -3.36% | -8.89% | — | |
| $88.09 | $379.01B | 28.98 | 1.87% | 28.56% | 40.44% | — | |
| $130.18 | $177.83B | 21.70 | 2.25% | 10.82% | 49.99% | — |
Ambev S.A. (ABEV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ABEV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ambev S.A. (ABEV) stock FAQ — growth, dividends, profitability & financials explained
Ambev S.A. (ABEV) reported $88.27B in revenue for fiscal year 2025. This represents a 1581% increase from $5.25B in 2000.
Ambev S.A. (ABEV) saw revenue decline by 1.4% over the past year.
Yes, Ambev S.A. (ABEV) is profitable, generating $16.25B in net income for fiscal year 2025 (17.6% net margin).
Yes, Ambev S.A. (ABEV) pays a dividend with a yield of 8.59%. This makes it attractive for income-focused investors.
Ambev S.A. (ABEV) has a return on equity (ROE) of 16.5%. This is reasonable for most industries.
Ambev S.A. (ABEV) generated $24.02B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
